Editorial commentary: Recurrent pericarditis in the era of interleukin-1 inhibition

Affiliations

¹ 1st Cardiology Clinic, National and Kapodistrian University of Athens, School of Medicine, Hippokration General Hospital Athens, Greece. Electronic address: glaz35@hotmail.com.
² 1st Cardiology Clinic, National and Kapodistrian University of Athens, School of Medicine, Hippokration General Hospital Athens, Greece.
³ 2nd Department of Medicine and Laboratory, Clinical Immunology-Rheumatology Unit, National and Kapodistrian University of Athens, School of Medicine, Hippokration General Hospital Athens, Greece.

Editorial

George Lazaros et al. Trends Cardiovasc Med. 2021 Jul.

. 2021 Jul;31(5):275-276.

doi: 10.1016/j.tcm.2020.04.010. Epub 2020 May 14.

¹ 1st Cardiology Clinic, National and Kapodistrian University of Athens, School of Medicine, Hippokration General Hospital Athens, Greece. Electronic address: glaz35@hotmail.com.
² 1st Cardiology Clinic, National and Kapodistrian University of Athens, School of Medicine, Hippokration General Hospital Athens, Greece.
³ 2nd Department of Medicine and Laboratory, Clinical Immunology-Rheumatology Unit, National and Kapodistrian University of Athens, School of Medicine, Hippokration General Hospital Athens, Greece.

No abstract available

Comment on

The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment.
Lopalco G, Rigante D, Cantarini L, Imazio M, Lopalco A, Emmi G, Venerito V, Fornaro M, Frediani B, Nivuori M, Brucato A, Iannone F. Lopalco G, et al. Trends Cardiovasc Med. 2021 Jul;31(5):265-274. doi: 10.1016/j.tcm.2020.04.006. Epub 2020 May 3. Trends Cardiovasc Med. 2021. PMID: 32376492 Review.